Recent Advances in the Treatment of Trichotillomania (Hair-Pulling Disorder)

    June 2020 in “ Dermatologic Therapy
    Gregory J. Everett, Mohammad Jafferany, Jonathon Skurya
    TLDR New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.
    Trichotillomania (TTM) is a hair-pulling disorder affecting 0.5% to 2.0% of the population, leading to significant psychological issues. While behavioral therapy has been effective, not all patients can adhere to it, highlighting the need for pharmacological treatments. Traditional medications like fluoxetine, clomipramine, olanzapine, and naltrexone have shown mixed results and often have limiting side effects. Recent advances in understanding TTM's pathophysiology have introduced new potential treatments, particularly glutamate-modulating agents such as N-acetylcysteine and dronabinol, which have shown promise in managing the disorder.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    3 / 3 results

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  146 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

    Similar Research

    6 / 1000+ results